Paradigm Biocapital Advisors »

Abivax SA F shares owned by Paradigm Biocapital Advisors

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Paradigm Biocapital Advisors from 13F filings

Historical chart of Paradigm Biocapital Advisors investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Paradigm Biocapital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Paradigm Biocapital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $133M 1.6M 84.90

More positions owned by Paradigm Biocapital Advisors

Nuvalent Inc-a (NUVL)
Merus N V Call Option (MRUS)
Arcellx Common Stock (ACLX)
Revolution Medicines (RVMD)
Tarsus Pharmaceuticals (TARS)
Vaxcyte (PCVX)
Abivax Sa Sponsored Ads (ABVX)
Genmab A/s Sponsored Ads (GMAB)
Agios Pharmaceuticals Call Option (AGIO)
Crinetics Pharmaceuticals In (CRNX)
Spdr Series Trust S&p Biotech Put Option (XBI)
Edgewise Therapeutics (EWTX)
Cidara Therapeutics Com New (CDTX)
Urogen Pharma (URGN)
Scholar Rock Hldg Corp (SRRK)

View all positions for Paradigm Biocapital Advisors

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Darwin Global Management
Point72 Asset Management
Cormorant Asset Management
Paradigm Biocapital Advisors
Caligan Partners
FMR
ADAR1 Capital Management
Octagon Capital Advisors
Millennium Management
Vestal Point Capital
Adage Capital Partners GP
Baker Bros. Advisors
Farallon Capital Management

View all funds holding Abivax SA F